$DYAI
Dyadic International Inc

2020 Q3 Form 10-Q Financial Statement

#000121380920000028 Filed on August 13, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2020 Q2 2019 Q2
Revenue $416.4K $524.3K $390.9K
YoY Change -8.39% 34.13% 142.35%
Cost Of Revenue $266.9K $624.2K $322.2K
YoY Change -30.63% 93.73% 149.56%
Gross Profit $149.4K -$99.97K $68.65K
YoY Change 114.38% -245.63% 113.39%
Gross Profit Margin 35.89% -19.07% 17.56%
Selling, General & Admin $1.640M $1.480M $1.870M
YoY Change 54.72% -20.86% 103.26%
% of Gross Profit 1097.49% 2724.12%
Research & Development $986.1K $1.116M $818.2K
YoY Change 17.2% 36.41% 36.1%
% of Gross Profit 659.87% 1191.97%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $986.1K $1.116M $818.2K
YoY Change 17.2% 36.41% 36.1%
Operating Profit -$2.576M -$2.798M -$2.962M
YoY Change 32.57% -5.52% 63.06%
Interest Expense $76.81K $146.6K $265.7K
YoY Change -68.65% -44.83% 21.01%
% of Operating Profit
Other Income/Expense, Net $76.81K
YoY Change
Pretax Income -$2.500M -$2.650M -$2.700M
YoY Change 47.06% -1.85% 68.75%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.499M -$2.651M -$2.696M
YoY Change 47.17% -1.65% 68.84%
Net Earnings / Revenue -600.32% -505.74% -689.68%
Basic Earnings Per Share
Diluted Earnings Per Share -$90.98K -$96.47K -$100.6K
COMMON SHARES
Basic Shares Outstanding 27.48M shares 27.47M shares 26.76M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.41M $31.83M $36.89M
YoY Change -14.24% -13.72% -16.78%
Cash & Equivalents $21.86M $11.78M $4.782M
Short-Term Investments $8.540M $20.05M $32.10M
Other Short-Term Assets $420.0K $600.0K $200.0K
YoY Change 425.0% 200.0% -74.68%
Inventory
Prepaid Expenses
Receivables $806.8K $564.7K $504.5K
Other Receivables $100.0K $730.0K $410.0K
Total Short-Term Assets $31.74M $33.73M $38.00M
YoY Change -12.94% -11.25% -16.63%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00 $1.520M
YoY Change -100.0% -100.0% 47.57%
Other Assets $5.558K $6.116K $51.58K
YoY Change -88.94% -88.14% -67.77%
Total Long-Term Assets $5.558K $6.116K $2.069M
YoY Change -99.73% -99.7% 73.85%
TOTAL ASSETS
Total Short-Term Assets $31.74M $33.73M $38.00M
Total Long-Term Assets $5.558K $6.116K $2.069M
Total Assets $31.75M $33.73M $40.07M
YoY Change -17.59% -15.82% -14.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $976.8K $1.144M $963.3K
YoY Change 36.92% 18.76% 318.81%
Accrued Expenses $620.6K $378.1K $396.0K
YoY Change 32.02% -4.52% 108.44%
Deferred Revenue $153.9K $41.38K $90.57K
YoY Change 64.95% -54.32%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.751M $1.638M $1.450M
YoY Change 37.16% 13.0% 208.48%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.751M $1.638M $1.450M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.750M $1.640M $1.450M
YoY Change 36.72% 13.1% 208.51%
SHAREHOLDERS EQUITY
Retained Earnings -$48.72M -$46.22M -$37.91M
YoY Change 22.98% 21.9%
Common Stock $39.74K $39.74K $39.37K
YoY Change 0.68% 0.94%
Preferred Stock
YoY Change
Treasury Stock (at cost) $18.90M $18.90M $18.93M
YoY Change 0.0% -0.16%
Treasury Stock Shares
Shareholders Equity $29.99M $32.09M $38.62M
YoY Change
Total Liabilities & Shareholders Equity $31.75M $33.73M $40.07M
YoY Change -17.59% -15.82% -14.33%

Cashflow Statement

Concept 2020 Q3 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$2.499M -$2.651M -$2.696M
YoY Change 47.17% -1.65% 68.84%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.390M -$1.900M -$1.430M
YoY Change -9.74% 32.87% -16.86%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $11.45M $8.930M $2.090M
YoY Change 801.57% 327.27% 574.19%
Cash From Investing Activities $11.45M $8.930M $2.090M
YoY Change 801.57% 327.27% 574.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 50.00K 150.0K
YoY Change -100.0% -66.67%
NET CHANGE
Cash From Operating Activities -1.390M -1.900M -1.430M
Cash From Investing Activities 11.45M 8.930M 2.090M
Cash From Financing Activities 0.000 50.00K 150.0K
Net Change In Cash 10.06M 7.080M 810.0K
YoY Change -11277.78% 774.07% -157.45%
FREE CASH FLOW
Cash From Operating Activities -$1.390M -$1.900M -$1.430M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001213809
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Entity Address Address Line1
EntityAddressAddressLine1
140 Intracoastal Pointe Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 404
dei Entity Address City Or Town
EntityAddressCityOrTown
Jupiter
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ServiceMember
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ServiceMember
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ServiceMember
CY2020Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ServiceMember
CY2017Q2 dyai Collaborative Arrangement Duration Of Agreement
CollaborativeArrangementDurationOfAgreement
P2Y
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55264
dei Entity Registrant Name
EntityRegistrantName
DYADIC INTERNATIONAL, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-0486747
dei Entity Address Address Line1
EntityAddressAddressLine1
140 Intracoastal Pointe Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 404
dei Entity Address City Or Town
EntityAddressCityOrTown
Jupiter
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33477
dei City Area Code
CityAreaCode
561
dei Local Phone Number
LocalPhoneNumber
743-8333
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
DYAI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27482157 shares
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
558530 USD
CY2020Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
500616 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11781549 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4823544 USD
CY2020Q2 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
20053019 USD
CY2019Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
29399146 USD
CY2020Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
226135 USD
CY2019Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
329711 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
564672 USD
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
250308 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
599514 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
277999 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
33725505 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
35639238 USD
CY2020Q2 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
0 USD
CY2019Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
1511636 USD
CY2020Q2 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
0 USD
CY2019Q4 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
250308 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6116 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
51314 USD
CY2020Q2 us-gaap Assets
Assets
33731621 USD
CY2019Q4 us-gaap Assets
Assets
37452496 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1143961 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
943378 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
378124 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
566003 USD
CY2020Q2 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
74955 USD
CY2019Q4 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
0 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
41376 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
78644 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1638416 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1588025 USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39735659 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39612659 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27482157 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27359157 shares
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
39736 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
39613 USD
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
97200023 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
96105851 USD
CY2019Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
12253502 shares
CY2020Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
12253502 shares
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
18929915 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
18929915 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46216639 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41351078 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
32093205 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
35864471 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33731621 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37452496 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
524271 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
390874 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
839643 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
793401 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
624240 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
322228 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
902422 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
650131 USD
CY2020Q2 dyai Provision For Contract Losses
ProvisionForContractLosses
74955 USD
CY2019Q2 dyai Provision For Contract Losses
ProvisionForContractLosses
0 USD
dyai Provision For Contract Losses
ProvisionForContractLosses
74955 USD
dyai Provision For Contract Losses
ProvisionForContractLosses
0 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1116163 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
818240 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1871616 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1510610 USD
CY2020Q2 dyai Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
0 USD
CY2019Q2 dyai Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
336310 USD
dyai Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
0 USD
dyai Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
725783 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1475232 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1870678 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3128624 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3298745 USD
CY2020Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-31690 USD
CY2019Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-4932 USD
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-42557 USD
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-10966 USD
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
3322280 USD
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
3352388 USD
us-gaap Costs And Expenses
CostsAndExpenses
6020174 USD
us-gaap Costs And Expenses
CostsAndExpenses
6196235 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2798009 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2961514 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5180531 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5402834 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-4865561 USD
CY2020Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
146587 USD
CY2019Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
265722 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
314970 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
532684 USD
CY2020Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-2651422 USD
CY2019Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-2695792 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-4870150 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
900 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-2651422 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-2695792 USD
us-gaap Net Income Loss
NetIncomeLoss
-4865561 USD
us-gaap Net Income Loss
NetIncomeLoss
-4871050 USD
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27467366 shares
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26828754 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27459415 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26771439 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
35864471 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
863552 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
230743 USD
us-gaap Net Income Loss
NetIncomeLoss
-4865561 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
32093205 USD
us-gaap Net Income Loss
NetIncomeLoss
-4865561 USD
us-gaap Net Income Loss
NetIncomeLoss
-4871050 USD
us-gaap Share Based Compensation
ShareBasedCompensation
863552 USD
us-gaap Share Based Compensation
ShareBasedCompensation
890166 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
229919 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
90785 USD
dyai Provision For Contract Losses
ProvisionForContractLosses
74955 USD
dyai Provision For Contract Losses
ProvisionForContractLosses
0 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-50204 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-10966 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-103576 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
105002 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-32112 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
189246 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
0 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-506866 USD
dyai Increase Decreasein Prepaid Researchand Development
IncreaseDecreaseinPrepaidResearchandDevelopment
0 USD
dyai Increase Decreasein Prepaid Researchand Development
IncreaseDecreaseinPrepaidResearchandDevelopment
-154522 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
321533 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-59867 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
154484 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
665126 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-188369 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3535 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-37268 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-50430 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3903929 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2840965 USD
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
14677156 USD
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
23571163 USD
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
25305000 USD
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
28676000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10627844 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5104837 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
230743 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
149180 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
230743 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
149180 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3347 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-17846 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6958005 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2395206 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4823544 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2386314 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11781549 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4781520 USD
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
0 USD
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
506866 USD
CY2020Q2 dyai Number Of Scientists Working Together
NumberOfScientistsWorkingTogether
3 scientist
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Use Of Estimates
UseOfEstimates
Use of EstimatesThe preparation of these consolidated financial statements in accordance with GAAP requires management to make estimates and judgments that affect the reported amount of assets and liabilities and related disclosure of contingent assets and liabilities at the date of our consolidated financial statements and the reported amounts of revenues and expenses during the applicable period. Actual results may differ from these estimates under different assumptions or conditions. Such differences could be material to the consolidated financial statements.
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentrations and Credit RiskThe Company’s financial instruments that are potentially subject to concentrations of credit risk consist primarily of cash and cash equivalents, investment securities, and accounts receivable. At times, the Company has cash, cash equivalents, and investment securities at financial institutions exceeding the Federal Depository Insurance Company (“FDIC”) and the Securities Investor Protection Corporation (“SIPC”) insured limit on domestic currency and the Netherlands’ FDIC counterpart for foreign currency. The Company only deals with reputable financial institutions and has not experienced any losses in such accounts.
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
564672 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
558530 USD
CY2020Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
416199 USD
CY2019Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
173890 USD
CY2020Q2 us-gaap Prepaid Insurance
PrepaidInsurance
166334 USD
CY2019Q4 us-gaap Prepaid Insurance
PrepaidInsurance
101221 USD
CY2020Q2 dyai Prepaid Research And Development
PrepaidResearchAndDevelopment
16261 USD
CY2019Q4 dyai Prepaid Research And Development
PrepaidResearchAndDevelopment
0 USD
CY2020Q2 us-gaap Prepaid Taxes
PrepaidTaxes
720 USD
CY2019Q4 us-gaap Prepaid Taxes
PrepaidTaxes
2888 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
599514 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
277999 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1143961 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
943378 USD
CY2020Q2 dyai Research And Development In Process Current
ResearchAndDevelopmentInProcessCurrent
1050481 USD
CY2019Q4 dyai Research And Development In Process Current
ResearchAndDevelopmentInProcessCurrent
766001 USD
CY2020Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5903 USD
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
26994 USD
CY2020Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
87577 USD
CY2019Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
150383 USD
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
285133 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
474388 USD
CY2020Q2 dyai Accrued Researchand Developmentin Process Current
AccruedResearchandDevelopmentinProcessCurrent
38711 USD
CY2019Q4 dyai Accrued Researchand Developmentin Process Current
AccruedResearchandDevelopmentinProcessCurrent
69795 USD
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
54280 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
21820 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
378124 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
566003 USD
CY2020Q2 dyai Research And Development Expense Outside Contracted Services
ResearchAndDevelopmentExpenseOutsideContractedServices
970846 USD
CY2019Q2 dyai Research And Development Expense Outside Contracted Services
ResearchAndDevelopmentExpenseOutsideContractedServices
658499 USD
dyai Research And Development Expense Outside Contracted Services
ResearchAndDevelopmentExpenseOutsideContractedServices
1584636 USD
dyai Research And Development Expense Outside Contracted Services
ResearchAndDevelopmentExpenseOutsideContractedServices
1243986 USD
CY2020Q2 dyai Research And Development Expense Contracted Services Related Party
ResearchAndDevelopmentExpenseContractedServicesRelatedParty
0 USD
CY2019Q2 dyai Research And Development Expense Facilities Overheadand Other
ResearchAndDevelopmentExpenseFacilitiesOverheadandOther
37451 USD
dyai Research And Development Expense Facilities Overheadand Other
ResearchAndDevelopmentExpenseFacilitiesOverheadandOther
23827 USD
dyai Research And Development Expense Facilities Overheadand Other
ResearchAndDevelopmentExpenseFacilitiesOverheadandOther
49572 USD
CY2019Q2 dyai Research And Development Expense Contracted Services Related Party
ResearchAndDevelopmentExpenseContractedServicesRelatedParty
336310 USD
dyai Research And Development Expense Contracted Services Related Party
ResearchAndDevelopmentExpenseContractedServicesRelatedParty
0 USD
dyai Research And Development Expense Contracted Services Related Party
ResearchAndDevelopmentExpenseContractedServicesRelatedParty
725783 USD
CY2020Q2 dyai Research And Development Expense Personnel Related Costs
ResearchAndDevelopmentExpensePersonnelRelatedCosts
139515 USD
CY2019Q2 dyai Research And Development Expense Personnel Related Costs
ResearchAndDevelopmentExpensePersonnelRelatedCosts
122290 USD
dyai Research And Development Expense Personnel Related Costs
ResearchAndDevelopmentExpensePersonnelRelatedCosts
263153 USD
dyai Research And Development Expense Personnel Related Costs
ResearchAndDevelopmentExpensePersonnelRelatedCosts
217052 USD
CY2020Q2 dyai Research And Development Expense Facilities Overheadand Other
ResearchAndDevelopmentExpenseFacilitiesOverheadandOther
5802 USD
CY2020Q2 dyai Research And Development Expense Including Related Party
ResearchAndDevelopmentExpenseIncludingRelatedParty
1116163 USD
CY2019Q2 dyai Research And Development Expense Including Related Party
ResearchAndDevelopmentExpenseIncludingRelatedParty
1154550 USD
dyai Research And Development Expense Including Related Party
ResearchAndDevelopmentExpenseIncludingRelatedParty
1871616 USD
dyai Research And Development Expense Including Related Party
ResearchAndDevelopmentExpenseIncludingRelatedParty
2236393 USD
CY2020Q2 dyai Income Tax Expense Benefit Valuation Allowance Reversal
IncomeTaxExpenseBenefitValuationAllowanceReversal
1001233 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2020Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
7600000 USD
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
7200000 USD
CY2019Q4 dyai Deferred Tax Assets Valuation Allowance Coverage Percent
DeferredTaxAssetsValuationAllowanceCoveragePercent
1
CY2020Q2 dyai Deferred Tax Assets Valuation Allowance Coverage Percent
DeferredTaxAssetsValuationAllowanceCoveragePercent
1
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4650390 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4650390 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4108390 shares
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4108390 shares
CY2020Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
11781549 USD
CY2020Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
11781549 USD
CY2020Q2 us-gaap Investments And Cash
InvestmentsAndCash
31927161 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
96852 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4259 USD
CY2020Q2 dyai Investmentsand Cash Amortized Cost
InvestmentsandCashAmortizedCost
31834568 USD
CY2019Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
4823544 USD
CY2019Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
4823544 USD
CY2019Q4 dyai Debt Securities Heldtomaturity Accumulated Unrecognized Loss Noncurrent
DebtSecuritiesHeldtomaturityAccumulatedUnrecognizedLossNoncurrent
0 USD
CY2019Q4 us-gaap Investments And Cash
InvestmentsAndCash
35738787 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
22452 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
17991 USD
CY2019Q4 dyai Investmentsand Cash Amortized Cost
InvestmentsandCashAmortizedCost
35734326 USD
CY2017Q2 dyai Collaborative Arrangement Paymentfor Researchand Development Agreement
CollaborativeArrangementPaymentforResearchandDevelopmentAgreement
1100000 USD
CY2017Q2 dyai Collaborative Arrangement Paymentfor Researchand Development Agreement
CollaborativeArrangementPaymentforResearchandDevelopmentAgreement
1000000 EUR
CY2020Q2 dyai Prepaid Research And Development
PrepaidResearchAndDevelopment
20000.00 USD
CY2019Q4 dyai Prepaid Research And Development
PrepaidResearchAndDevelopment
0 USD
CY2020Q2 dyai Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
0 USD
CY2019Q2 dyai Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
300000 USD
dyai Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
0 USD
dyai Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
700000 USD
CY2020Q2 dyai Revenue From Collaborative Arrangement Recognized
RevenueFromCollaborativeArrangementRecognized
99260 USD
dyai Revenue From Collaborative Arrangement Recognized
RevenueFromCollaborativeArrangementRecognized
174632 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4650390 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3860390 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3860390 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.76
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y8M12D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
13287932 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
913000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.24
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
123000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.88
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4650390 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.44
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y1M6D
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
28939039 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3250294 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.76
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
22413471 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
123000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.88
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
436614 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
580603 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
863552 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
890166 USD
dyai Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Common Stock Issued
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodCommonStockIssued
123000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.88
CY2020Q2 dyai Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Common Stock Issued
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodCommonStockIssued
397671 shares
CY2020Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.59
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
35864471 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
426939 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
175000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-2214139 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
34252271 USD
CY2020Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
436613 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
55743 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-2651422 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
32093205 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
42451169 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
309563 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-2175258 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
40585474 USD
CY2019Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
149180 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
580603 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-2695792 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
38619465 USD
CY2019Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
12253502 shares
CY2020Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
12253502 shares
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
18900000 USD
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
18900000 USD

Files In Submission

Name View Source Status
0001213809-20-000028-index-headers.html Edgar Link pending
0001213809-20-000028-index.html Edgar Link pending
0001213809-20-000028.txt Edgar Link pending
0001213809-20-000028-xbrl.zip Edgar Link pending
dyai-20200630.htm Edgar Link pending
dyai-20200630.xsd Edgar Link pending
dyai-20200630_cal.xml Edgar Link unprocessable
dyai-20200630_def.xml Edgar Link unprocessable
dyai-20200630_g1.jpg Edgar Link pending
dyai-20200630_htm.xml Edgar Link completed
dyai-20200630_lab.xml Edgar Link unprocessable
dyai-20200630_pre.xml Edgar Link unprocessable
exhibit311certificatio.htm Edgar Link pending
exhibit312certificatio.htm Edgar Link pending
exhibit321sec1350certi.htm Edgar Link pending
exhibit322sec1350certi.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending